Aldevron is a biotechnology and manufacturing startup with a strong emphasis on breakthrough innovations. Founded in 1998, the company's recent Private Equity Round investment at 01 January 2019 was made by CPP Investments. Aldevron's merger with Danaher has positioned the company at the forefront of the industry, allowing them to offer unparalleled expertise and solutions to customers. This collaboration with Danaher's businesses in biotechnology, diagnostics, and life sciences aims to unlock the transformative potential of cutting-edge science and technology, ultimately improving the lives of billions of people every day. As a United States-based company, Aldevron is primed to make significant contributions to the biotechnology and manufacturing industries.
No recent news or press coverage available for Aldevron.